Ruti Aga and the Six-Year Arithmetic: How a Forged Prescription Killed the Defence That Could Have Worked

The tenth of September. Ruti Aga's career clock has been running backwards from that date, and when the Athletics Integrity Unit released its statement on Thursday, the sharpest fact in it was not a finishing time. It was a clinic address.

The Ethiopian marathoner explained her positive sample with a knee injury. A methylprednisolone injection, clinically legitimate, which she had taken. The person who wrote the prescription was a family member with no medical registration, who claimed he had used "an old prescription pad from a former workplace." The clinic named on the document did not exist. And the clinic whose pad was invoked stated plainly that no such pad had ever belonged to it.

Three separate verifications. Three separate failures. That is why the arithmetic reads six years rather than two.

I read Thursday's statement the way I used to open England Athletics result files and AFI results PDFs in 2026 — source first, date second, sample size third, opinion last, and often not at all. In this case the arithmetic does most of the talking. Two plus four equals six. The question is what the sum is made of, and why a substance that cannot make a marathoner one second faster has become the instrument for ending an eight-year career.

The race nobody timed

Start with the place where it happened. According to the AIU statement, the sample was collected after a half marathon in China in March, and Aga won that race. Beyond that, the statement gives nothing — no mark, no splits, no field strength, no weather, no margin.

The silence is itself information. I have spent years pulling stories out of results sheets, and the habit says that where the performance number is missing, the performance verdict should be missing too. "She won" does not tell you what shape she was in. For a 2:18 marathoner, winning a Chinese label race is evidence of usable form; it is not a measurement of it.

What is technically settled, and what almost nobody wrote, is the testing window. In road races the in-competition window opens at 23:59 the day before the race. An injection given into a knee four days earlier will be caught on race day if residues remain. That is the technical detail the whole case rests on, and the one most reports buried under the word "steroid."

The mixed zone is where the stopwatch hands its authority to the sentence. In Tampere in 2026, in the mixed zone at the World U20 Championships, I asked Hima Das for her 200-metre split rather than for a quote about hardship. A veteran correspondent beside me suggested the women's 400 metres was "a nice story." I went back to the results file and built the case from 51.46 instead. The same habit has me asking, today, what the mark was in that March race in China — because without it, no honest assessment of her condition is possible.

What survives the ledger

The record that survives is excellent, and I am not among those who will bury it. Public results show Aga won the 2026 Tokyo Marathon and finished second three times at World Marathon Majors. Figures such as 2:18:34 in Berlin 2026 and 2:20:40 in Tokyo 2026 sit in my notes; those are working numbers from my own files and should be re-checked against official results before being quoted as settled. But a 2:18-to-2:20 range and three Major podiums are enough to establish that this was not a mid-tier athlete.

The most important unstated fact in this case is that her record before the March race is not automatically annulled. The violation is anchored to that event, and absent a finding of earlier use, the 2026 Major title and the rest of the record stand. The distinction matters, because the easiest reaction to a sanction headline is to erase the entire career. The ledger says otherwise. It says a runner was genuinely fast, and later made a bad decision. Both are true at once, and both have to be written at once.

Two and four

Now the part almost nobody looked at properly. Six years is not a single sanction. It is the sum of two separate violations, and the split tells you everything.

Two years for the presence violation, four years for tampering — six in total. Two years is the standard outcome when a panel accepts that the substance was in the body but intent to cheat is not proven. In other words, on the substance she initially got the softer end. Four years is the Code's standard sanction for a fabricated document or a misleading statement. Added together, they make six, and the addition tells you the panel was lenient on the first violation and immovable on the second.

There is a quiet paradox here worth naming. A forged prescription is itself circumstantial evidence of an intent to conceal. Yet it did not escalate the presence sanction; it was billed separately. Technically clean, strategically ruinous, because it means a single error was invoiced twice.

Backdating to 10 September is not a discount. Time served under provisional suspension counts against the ban, which means she was already out for that period. Nothing was gained. The statement does not give a year, so I will not write the exact expiry date — filling a gap with a guess is the oldest bad habit in this trade.

The substance is not what the papers said

Here I have to make a technical correction, and it changes the shape of the case.

Methylprednisolone is a glucocorticoid, WADA Prohibited List class S9 — not an anabolic steroid. And S9 is prohibited in-competition only, by injection, oral or rectal route. The same injection given out of competition is entirely lawful, provided no residue is present on race day.

Which means the case never really turned on the drug. It turned on route and timing relative to the competition. That was the ground on which a defensible explanation could have been built: here is the treatment, here is the record, here is the route, here is the clearance interval, the residue was present but the intent was therapeutic.

And that is exactly where the story turns. By manufacturing the prescription, she burned the only defence that could have held. I try to understand that rather than simply condemn it, because condemnation is cheap and understanding is useful. The pressure on an injured marathoner is direct: appearance-fee contracts, the next Major, a sponsor's attention, and a body that demands 180 kilometres a week. Glucocorticoids are the cheapest available tool for masking that pain. And when it comes to fabricating paperwork, the fabrication is itself evidence that nobody around her could produce the real thing.

Three checks, three failures

The most painful element in this case is not a chemical. It is a piece of paper.

First check: the clinic's existence. The institution named on the prescription did not exist. Second: the licence. The author had no medical registration and was a family member. Third: the source of the pad. He said he had used an old pad from a former workplace, and the clinic in question denied it had ever issued one.

Three checks, three catches. This is not carelessness. Carelessness leaves one crack. This is the kind of case where the forger did not even do the basic groundwork, because he assumed nobody would ask.

Which is where my interest shifts from the athlete to the people around her. The AIU statement names only the family member. Not the agent, not the manager, not the camp doctor who presumably administered the injection. Whether any of them was investigated, the statement does not say. What it does say is that accountability stopped at one individual.

I keep a private list of athletes who never made the highlights and check it annually. In Guwahati in January 2026, at the Khelo India Youth Games, I logged 380 athletes in three days, photographed runways and hand-timed approaches. In March the consultancy froze travel, cut the scouting unit from nine to three, and I survived on my database alone. That year I rewrote the observation protocol for video — twelve camera angles, thirty-frame release analysis, remote coach interviews — and hit its limit: a 19-year-old javelin thrower's elbow I could not examine, flagged "unverified" in three consecutive reports. That vocabulary is the one I am using here. What the AIU has stated is verified. What it has not stated — the agent's role, the history of earlier treatment, the fate of the March result — is unverified, and I will call it that.

The economics of appearance and the economics of testing

This case cannot be read through a professional-sport template, because that template does not exist in this world.

An Ethiopian marathoner's real income is not prize money. It is appearance fees, an agent's contract, and the label-race circuit in China and the Gulf between Majors. For a 2:18 athlete, that is the ideal model: few races, large fees, low risk. Aga's recent calendar appears to lean that way — selective Majors, Asian label races in between.

That same circuit is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same races. Where the money is dense, the field is dense; where the field is dense, so are the samples. Results from this tier will carry integrity risk for years.

Here I have to manage my oldest instinct — the comparison reflex. Being raised in Kenya and based in Britain makes it very easy to write that something is structurally wrong with East African road running. I will not. Compare systems, not peoples: camp economics, the depth of the domestic calendar, coaching pipelines, the cost of a season, and above all whose budget pays for a medical officer in a camp. In this case the answer is clear. Nobody's.

Appearance fees price the present; the medical register is where the future stays unlisted.

What I will not conclude

Now the part where I have to argue with my own temperament. The INTJ instinct is to find the pattern, and when the file contains a forgery, the takedown starts to feel like the finding. Three things need saying plainly instead.

First: four of the six years are for the paper, not the substance. Those who will frame this as a harsh sentence for a glucocorticoid are misreading the sum. The drug cost two years, and only because intent was not proven. The other four are the price of misleading an investigation, which every testing system treats as its most serious offence. If the verification system itself can be lied to, the rest of the argument is theatre.

Second, and more uncomfortable: six years for a substance with no proven endurance benefit will be cited both as evidence of AIU rigour and as evidence of inconsistent enforcement against African road runners. I cannot settle that argument, because I do not have the full comparative dataset. What I can say is that the day a public, dated, substance-by-substance ledger of these sanctions exists, the argument will be settled by numbers rather than by tweets.

Third, the sharpest point of all: Ethiopia's women's marathon depth is such that the removal of a 32-year-old changes nothing in selection arithmetic. Her three Major second places were commercial-tier results, not championship conversions. That cuts both ways. It says the sport will not feel her absence, which is cruel. It also says that an individual capable of taking this risk was very alone inside the system — because in a system where places are that cheap, nobody is responsible for protecting anyone.

Not finished

In Tampere the race lasted forty-nine seconds; the story has not finished yet. The same applies here. Thursday's statement closes a case. It does not close the ecology that produced it.

The next time an Ethiopian or Kenyan runner returns a positive sample and a faded, hand-written prescription surfaces alongside it, remember that the paper is not one person's stupidity. It is a map of the place where medical support never arrived. The question is not why Ruti Aga had a document forged. The question is why there was nobody in that camp who could have issued a real one.